Allied Health Care Products
| 2012 | | Capella University MBA 6008; Global Economics
LYNETTE E. DZWIELEWSKI |
[aLLIED HEALTHCARE PRODUCTS, INC.] | |
Health economics is a subdivision of economics central to issues correlated with the effectiveness, significance and performance in the structure, production and utilization of the healthcare industry—and the evaluation of numerous categories of calculated financial information including: measured value, consumer costs and industry expenditures. In general terms, health economists analyze the health effects of behaviors—the finances, efficacy and operations of health care systems —and the competitive symmetry in the five health markets. The five health markets generally studied are: * Health care financing market * Physician and nurses services market * Institutional services market * Input factors market * Professional education market
While the current quality or condition to change in healthcare as a private benefit is preserved, in the last three markets, market failures result in the financing and delivery markets because accurate information about product price is not a pragmatic conjecture—and various limits of access exist in the financing markets; such as the monopolistic structure of the health insurance industry.
Medical technology is generally classified as an Institutional Services Market and encompasses of all aspects involved in the treatment of disease—which includes the utilization of medical devices, and surgical and pharmaceutical interventions—and is of vital importance in relation to individual health and, as a result, for general wellbeing. Progress and advanced developments in medical technology transmit a vista of both enhanced public health and increased universal welfare. However, due to extensive governmental regulations concerning the healthcare goods and services markets; the developments, improvements and utility of medical technologies essentially differs
LYNETTE E. DZWIELEWSKI |
[aLLIED HEALTHCARE PRODUCTS, INC.] | |
Health economics is a subdivision of economics central to issues correlated with the effectiveness, significance and performance in the structure, production and utilization of the healthcare industry—and the evaluation of numerous categories of calculated financial information including: measured value, consumer costs and industry expenditures. In general terms, health economists analyze the health effects of behaviors—the finances, efficacy and operations of health care systems —and the competitive symmetry in the five health markets. The five health markets generally studied are: * Health care financing market * Physician and nurses services market * Institutional services market * Input factors market * Professional education market
While the current quality or condition to change in healthcare as a private benefit is preserved, in the last three markets, market failures result in the financing and delivery markets because accurate information about product price is not a pragmatic conjecture—and various limits of access exist in the financing markets; such as the monopolistic structure of the health insurance industry.
Medical technology is generally classified as an Institutional Services Market and encompasses of all aspects involved in the treatment of disease—which includes the utilization of medical devices, and surgical and pharmaceutical interventions—and is of vital importance in relation to individual health and, as a result, for general wellbeing. Progress and advanced developments in medical technology transmit a vista of both enhanced public health and increased universal welfare. However, due to extensive governmental regulations concerning the healthcare goods and services markets; the developments, improvements and utility of medical technologies essentially differs
References: Acquisitions, T. M. (1985-1996). Allied Healthcare Products, Inc. Thomas Reuters. al., A. e. (May 8, 2001). Patent No. US 6,228,150 B1. Allied Healthcare Products, I ALLIED HEALTHCARE PRODUCTS, I. (2011). Form 10-K: Annual Report Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934. Washington, DC: United States Securities and Exchange Commission. Allied Healthcare Products, I. (2011). History of Allied Healthcare Products. Retrieved from About Allied: http://www.alliedhpi.com/history.htm Allied Healthcare Products, I Allied Healthcare Products, Inc. v. Armstrong Medical Ltd., 4:11-cv-00972 (United States District Court For the Eastern District of Missouri Eastern Division May 27, 2011). Consumer Reports Magazine. (2012). Dangerous Devices. Consumer Reports Magazine. FDA.gov. (2012). Recalls, Market Withdrawals, & Safety Alerts. Silver Spring, MD: U.S. Food and Drug Administration. Fuchs, V. (2005). Health, Government, and Irving Fisher. American Journal of Economics and Sociology, 407-426. Gelijns, A. C. (1991). The Changing Economics of Medical Technology. Washington, DC : Committee on Technological Innovation in Medicine, Institute of Medicine . Gottlieb, S. (2009). How the U.S Government Rations Health Care. Wall Street Journal, A.23-A.23. Grossman, M., Lindgren, B., & Bolin, K. a. (2011). The Economics of Medical Technology. Washington, DC: Emerald Group Publishing. Institute of Medicine of the National Academies. (July 29, 2011 ). Report Brief: Medical Devices and the Public’s Health: The FDA 510(k) Clearance Process at 35 Years. Institute of Medicine of the National Academies. John Robertson, C. A. (2008). Patent No. 20080210091. Allied Healthcare Products, Inc.--St. Louis, MO. Maisel, W. (February 17, 2004). Medical Device Regulation: An Introduction for the Practicing Physician. Annals of Internal Medicine, 296-302. Munsey, R. R. (1995). Trends and Events in FDA Regulation of Medical Devices Over the Last Fifty Years. Food and Drug Law Journal 50, Special Issue, 163-177. Shein, M. &. (2008). FDA Viewpoint. Pacing and Clinical Electrophysiology, 31(1): 16. Wall Street Journal. (1999). Allied Healthcare Products Inc. Wall Street Journal.